Texas Biomed shares critical work in development of Pfizer COVID vaccine

Texas Biomed shares critical work in development of Pfizer COVID vaccine
Virtual Global Health Symposium April 29-30, 2021 will highlight role of preclinical research in vaccine development
News provided by
Share this article
Share this article
SAN ANTONIO, April 27, 2021 /PRNewswire/ -- When the world was coming to grips with an emerging global pandemic a year ago, scientists at Texas Biomedical Research Institute sprang into action. The rhesus macaques at the Southwest National Primate Research Center (SNPRC) at Texas Biomed were quickly validated as models for studying vaccines designed to protect humans against SARS-CoV-2, the virus that causes COVID-19. The Pfizer-BioNTech COVID-19 vaccine was tested in this model at the Institute and has now been given to millions of people around the world.

Related Keywords

China ,United States ,Ricardo Carrion ,Isis Kanevsky ,Larry Schlesinger ,Pfizer ,Containment Contract Research ,National Institutes Of Health ,Drug Administration ,Virtual Global Health Symposium ,Biomedical Engineering Institute Resources Repository ,Texas Biomed ,Nature Microbiology ,National Institutes ,Maximum Containment Contract ,Middle East Respiratory Syndrome ,Virtual Global Health ,Director Bacterial Vaccines ,Emergency Use Authorization ,Coronavirus Disease ,Fact Sheet ,Healthcare Providers Administering Vaccine ,Vaccination Providers ,சீனா ,ஒன்றுபட்டது மாநிலங்களில் ,ரிக்கார்டோ கேரியன் ,லாரி ஶ்லெஸிந்‌ஜர் ,ஃபைசர் ,தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் ,டெக்சாஸ் பயோமெட் ,இயற்கை நுண்ணுயிரியல் ,தேசிய நிறுவனங்கள் ,நடுத்தர கிழக்கு சுவாச நோய்க்குறி ,அவசரம் பயன்பாடு அங்கீகாரம் ,உண்மை தாள் ,தடுப்பூசி வழங்குநர்கள் ,